-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Hold on Edwards Lifesciences, Raises Price Target to $75

Benzinga·04/25/2025 11:53:26
Listen to the news
Canaccord Genuity analyst William Plovanic maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target from $71 to $75.